As demand for CAR T therapies strain traditional manufacturing, Autolus Therapeutics has tapped Cellares to evaluate whether that company’s automated Cell Shuttle platform can support expanded ...
The researchers say that, to their knowledge, this is the first demonstration of programmable, site-specific integration of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results